Global Performance Enhancing Drugs Market Growth 2023-2029

Global Performance Enhancing Drugs Market Growth 2023-2029

Performance-enhancing drugs (PED), are substances that are used to improve any form of activity performance in humans.

LPI (LP Information)' newest research report, the “Performance Enhancing Drugs Industry Forecast” looks at past sales and reviews total world Performance Enhancing Drugs sales in 2022, providing a comprehensive analysis by region and market sector of projected Performance Enhancing Drugs sales for 2023 through 2029. With Performance Enhancing Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Performance Enhancing Drugs industry.

This Insight Report provides a comprehensive analysis of the global Performance Enhancing Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Performance Enhancing Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Performance Enhancing Drugs market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Performance Enhancing Drugs and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Performance Enhancing Drugs.

The global Performance Enhancing Drugs market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

A well-known example of PED involves doping in sport, where banned physical performance–enhancing drugs are used by athletes and bodybuilders. Athletic performance-enhancing substances are sometimes referred to as ergogenic aids. Cognitive performance-enhancing drugs, commonly called nootropics, are sometimes used by students to improve academic performance. Performance-enhancing substances are also used by military personnel to enhance combat performance.

This report presents a comprehensive overview, market shares, and growth opportunities of Performance Enhancing Drugs market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
Pills
Injections
Patches

Segmentation by application
Athletes
Students
Militaries
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Taj Pharmaceuticals
Balkan Pharmaceuticals
Bayer
AstraZeneca
Novo Nordisk
BrainAlert
Douglas Laboratories
Onnit Labs
Eli Lilly And Company

Key Questions Addressed in this Report

What is the 10-year outlook for the global Performance Enhancing Drugs market?

What factors are driving Performance Enhancing Drugs market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Performance Enhancing Drugs market opportunities vary by end market size?

How does Performance Enhancing Drugs break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.